0.4349
-0.0151
(-3.36%)
As of 1:10:06 PM EST. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 31.9M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SHAH JAISIM Chief Executive Officer | Purchase at price 0.46 per share. | Direct | 13,800 | Dec 18, 2024 |
| JI HENRY H Officer and Director | Purchase at price 0.94 per share. | Direct | 8,351 | Oct 31, 2024 |
| SHAH JAISIM Chief Executive Officer | Purchase at price 0.99 per share. | Direct | 31,670 | Oct 29, 2024 |
| FOLLOWWILL DORMAN Director | Purchase at price 0.99 per share. | Direct | 990 | Oct 18, 2024 |
| CHUN JAY Director | Purchase at price 0.95 per share. | Direct | 4,750 | Oct 18, 2024 |
| JI HENRY H Officer and Director | Purchase at price 0.97 per share. | Indirect | 9,710 | Oct 17, 2024 |
| WU YUE ALEXANDER Director | Purchase at price 0.95 per share. | Direct | 18,992 | Oct 17, 2024 |
| LEMUS DAVID Director | Purchase at price 0.90 per share. | Direct | 1,800 | Oct 17, 2024 |
| SHAH JAISIM Chief Executive Officer | Purchase at price 0.99 per share. | Direct | 29,751 | Oct 16, 2024 |
| MA STEPHEN HOI Chief Financial Officer | Purchase at price 0.97 per share. | Direct | 6,499 | Oct 16, 2024 |
| FOLLOWWILL DORMAN Director | Conversion of Exercise of derivative security at price 1.37 per share. | Direct | 1,370 | Jun 26, 2024 |
| SHAH JAISIM Chief Executive Officer | Conversion of Exercise of derivative security at price 1.73 per share. | Direct | 24,220 | Jun 20, 2024 |
| WU YUE ALEXANDER Director | Conversion of Exercise of derivative security at price 1.41 per share. | Direct | 7,050 | Jun 20, 2024 |
| CHUN JAY Director | Conversion of Exercise of derivative security at price 1.41 per share. | Direct | 7,050 | Jun 20, 2024 |
| MA STEPHEN HOI Chief Financial Officer | Conversion of Exercise of derivative security at price 1.41 per share. | Direct | 2,820 | Jun 20, 2024 |
| JI HENRY H Officer and Director | Conversion of Exercise of derivative security at price 1.41 per share. | Direct | 8,460 | Jun 18, 2024 |
| SHAH JAISIM Officer and Director | Conversion of Exercise of derivative security at price 1.41 per share. | Direct | 47,000 | Jun 14, 2024 |
| SHAH JAISIM Chief Executive Officer | Purchase at price 0.84 - 0.92 per share. | Indirect | 121,945 | May 17, 2024 |
| JI HENRY H Officer and Director | Purchase at price 0.88 per share. | Indirect | 43,985 | May 17, 2024 |
| CHUN JAY Director | Purchase at price 0.90 per share. | Direct | 51,641 | May 17, 2024 |
| MA STEPHEN HOI Chief Financial Officer | Purchase at price 0.88 per share. | Direct | 12,443 | May 17, 2024 |
| SORRENTO THERAPEUTICS, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.75 per share. | Direct | 105,120,024 | Sep 21, 2023 |
Related Tickers
AMRN Amarin Corporation plc
0.5735
+1.50%
MIRA MIRA Pharmaceuticals, Inc.
1.2900
+13.16%
SNY Sanofi
54.42
+4.35%
AZN AstraZeneca PLC
71.24
+1.41%
GILD Gilead Sciences, Inc.
96.57
+1.03%
BIIB Biogen Inc.
147.58
+2.19%
GSK GSK plc
35.40
+0.97%
BAYRY Bayer Aktiengesellschaft
5.74
+1.41%
RHHBY Roche Holding AG
39.31
+1.16%
PFE Pfizer Inc.
26.94
+1.18%